P40338 (VHL_MOUSE) Reviewed, UniProtKB/Swiss-Prot
Last modified
April 3, 2013.
Version 104.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Von Hippel-Lindau disease tumor suppressor Alternative name(s): pVHL | ||||
| Gene names |
| ||||
| Organism | Mus musculus (Mouse) [Reference proteome] | ||||
| Taxonomic identifier | 10090 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Glires › Rodentia › Sciurognathi › Muroidea › Muridae › Murinae › Mus › Mus![]() |
Protein attributes
| Sequence length | 181 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at transcript level |
General annotation (Comments)
| Function | Involved in the ubiquitination and subsequent proteasomal degradation via the von Hippel-Lindau ubiquitination complex. Seems to act as target recruitment subunit in the E3 ubiquitin ligase complex and recruits hydroxylated hypoxia-inducible factor (HIF) under normoxic conditions. Involved in transcriptional repression through interaction with HIF1A, HIF1AN and histone deacetylases. Ubiquitinates, in an oxygen-responsive manner, ADRB2 By similarity. |
| Pathway | |
| Subunit structure | Component of the VCB (VHL-Elongin BC-CUL2) complex; this complex acts as a ubiquitin-ligase E3 and directs proteasome-dependent degradation of targeted proteins. Interacts with CUL2; this interaction is dependent on the integrity of the trimeric VBC complex. Interacts (via the beta domain) with HIF1A (via the NTAD domain); this interaction mediates degradation of HIF1A in normoxia and, in hypoxia, prevents ubiqitination and degradation of HIF1A by mediating hypoxia-induced translocation to the nucleus, a process which requires a hypoxia-dependent regulatory signal. Interacts with ADRB2; the interaction, in normoxia, is dependent on hydroxylation of ADRB2 and the subsequent VCB-mediated ubiquitination and degradation of ADRB2. Under hypoxia, hydroxylation, interaction with VHL, ubiquitination and subsequent degradation of ADRB2 are dramatically decreased. Interacts with RNF139, USP33 and PHF17 By similarity. Found in a complex composed of LIMD1, VHL, EGLN1/PHD2, TCEB2 AND CUL2. Interacts with LIMD1 (via LIM zinc-binding 2). Interacts with AJUBA (via LIM domains) and WTIP (via LIM domains) By similarity. Interacts with EPAS1 By similarity. |
| Subcellular location | Cytoplasm By similarity. Membrane; Peripheral membrane protein By similarity. Nucleus By similarity. Note: Colocalizes with ADRB2 at the cell membrane By similarity. |
| Developmental stage | Expressed throughout fetal nephrogenesis, abdominal and thoracic organogenesis, and nervous system development between day 10.5 and day 16.5. In the developing lung, differential expression within the endodermally derived cuboidal epithelial lining of the terminal and respiratory bronchioles. In the developing eye, high expression in both the inner and outer neuroblastic layers of the retina and lens. Ref.1 |
| Domain | The Elongin BC complex binding domain is also known as BC-box with the consensus [APST]-L-x(3)-C-x(3)-[AILV]. |
Ontologies
Sequence annotation (Features)
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Expression of the Von Hippel-Lindau tumor suppressor gene, VHL, in human fetal kidney and during mouse embryogenesis." Kessler P.M., Vasavada S.P., Rackley R.R., Stackhouse T., Duh F.-M., Latif F., Lerman M.I., Zbar B., Williams B.R. Mol. Med. 1:457-466(1995) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], DEVELOPMENTAL STAGE. Strain: ICR. Tissue: Brain. |
| [2] | "Cloning and characterization of a mouse gene with homology to the human von Hippel-Lindau disease tumor suppressor gene: implications for the potential organization of the human von Hippel-Lindau disease gene." Gao J., Naglich J.G., Laidlaw J., Whaley J.M., Seizinger B.R., Kley N. Cancer Res. 55:743-747(1995) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. |
| [3] | "Human DNA blueprints protecting the VHL promoter and CpG island from methylation are functional in the mouse." Kuzmin I., Geil L., Schmidt L., Duh F.-M., Feigenbaum L., Nickerson M.L., Ma W., Stanbridge E.J., Zbar B., Lerman M.I. Submitted (MAY-2002) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE. Strain: 129/SvJ. |
| [4] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Strain: C57BL/6. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | U12570 mRNA. Translation: AAA20662.1. S76748 mRNA. Translation: AAB33363.1. AF513984 Genomic DNA. Translation: AAM53645.1. BC052417 mRNA. Translation: AAH52417.2. |
| IPI | IPI00109233. |
| RefSeq | NP_033533.1. NM_009507.3. |
| UniGene | Mm.29407. |
3D structure databases | |
| ProteinModelPortal | P40338. |
| SMR | P40338. Positions 28-170. |
| ModBase | Search... |
Protein-protein interaction databases | |
| IntAct | P40338. 4 interactions. |
| STRING | 10090.ENSMUSP00000039418. |
PTM databases | |
| PhosphoSite | P40338. |
Proteomic databases | |
| PaxDb | P40338. |
| PRIDE | P40338. |
Protocols and materials databases | |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENSMUST00000035673; ENSMUSP00000039418; ENSMUSG00000033933. |
| GeneID | 22346. |
| KEGG | mmu:22346. |
Organism-specific databases | |
| CTD | 7428. |
| MGI | MGI:103223. Vhl. |
Phylogenomic databases | |
| eggNOG | NOG327868. |
| HOGENOM | HOG000030904. |
| HOVERGEN | HBG044781. |
| InParanoid | P40338. |
| KO | K03871. |
| OMA | NTREPSQ. |
| OrthoDB | EOG4J119K. |
Enzyme and pathway databases | |
| UniPathway | UPA00143. |
Gene expression databases | |
| ArrayExpress | P40338. |
| Bgee | P40338. |
| Genevestigator | P40338. |
| GermOnline | ENSMUSG00000033933. Mus musculus. |
Family and domain databases | |
| Gene3D | 1.10.750.10. 1 hit. 2.60.40.780. 1 hit. |
| InterPro | IPR002714. Tumour_suppress_VHL-disease. IPR024048. VHL_alpha_dom. IPR024053. VHL_beta_dom. IPR022772. VHL_tumour_suppress_b/a_dom. [Graphical view] |
| PANTHER | PTHR15160. PTHR15160. 1 hit. |
| Pfam | PF01847. VHL. 1 hit. [Graphical view] |
| SUPFAM | SSF49468. SSF49468. 1 hit. |
| ProtoNet | Search... |
Other | |
| NextBio | 302621. |
| SOURCE | Search... |
Entry information
| Entry name | VHL_MOUSE | ||||||||
| Accession | Primary (citable) accession number: P40338 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
Relevant documents
| MGD cross-references Mouse Genome Database (MGD) cross-references in UniProtKB/Swiss-Prot |
| PATHWAY comments Index of metabolic and biosynthesis pathways |

Clusters with
